# Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects

> **NCT06308393** · PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 98 (actual)

## Conditions studied

- Healthy
- Psoriatic Subjects

## Interventions

- **DRUG:** RSS0393 ointment；Placebo

## Key facts

- **NCT ID:** NCT06308393
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-03-01
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 98 (ACTUAL)
- **Last updated:** 2025-05-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06308393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06308393, "Randomized, Double-blind, Placebo-controlled Study of RSS0393 Ointment in Healthy and Psoriatic Subjects". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06308393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*